Alzheimer’s disease is the most common cause of dementia, and the Asia Pacific region is expected to contribute to more than half of all global dementia cases by 2030.
Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug…
Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR In
Read more